Benefits of Immersive Virtual Reality on Dyspnoea During a Weaning Test in the Intensive Care Unit.

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 23, 2024

Keywords

ClinConnect Summary

A weaning trial is a test that simulates physiological respiratory conditions after extubation in order to assess the patient's ability to breathe without the assistance of a ventilator.

This test is highly susceptible to induce dyspnea, with 62% of patients reporting a dyspnea score on VAS greater than 3.

Similarly, the prevalence of anxiety is high during weaning trials. 60% of patients treated in a respiratory weaning unit report psychological symptoms.

Dyspnea can be a traumatic experience for patients. In intensive care, up to half of patients suffer from dyspnea, which is described...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 18 years
• • 2. Patients intubated and on mechanical ventilation for more than 24 hours
• • 3. Patients eligible for a weaning trial (resolution of acute phase of pathology, low bronchial congestion, effective cough, SpO2 \> 90% with Fio2 \< 40%, PEEP \< 8 cmH20, respiratory rate \< 40/min, haemodynamically stable)
• • 4. Decision by the doctor in charge to initiate a respiratory weaning trial as part of treatment
• • 5. RASS score between -1 and +1
• • 6. Patient able to answer questionnaires
• • 7. Informed of the study and whose free and informed written consent has been obtained
• • 8. Beneficiary of a social security plan (excluding AME)
• Exclusion Criteria:
• • 1. Non french speaker
• • 2. Acute confusion or cognitive disorders
• • 3. No reliable assessment of dyspnea
• • 4. Acrophobia
• • 5. Claustrophobia
• • 6. Photophobia
• • 7. Hearing loss
• • 8. Visual impairment
• • 9. Subject under guardianship or curatorship